Finance

Lists
BAFNAPH:NSE
Bafna Pharmaceuticals Ltd
₹242.45
+2.00%
(+4.75) 1D
Aug 21, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BAFNAPH...
Open
₹232.95
High
₹242.45
Low
₹232.95
Mkt. cap
5.73B
Avg. vol.
0.00
Volume
23.66K
P/E ratio
73.69
52-wk high
₹290.70
52-wk low
₹91.20
EPS
₹3.29
No. of employees
406
Open
₹232.95
High
₹242.45
Low
₹232.95
Mkt. cap
5.73B
Avg. vol.
0.00
Volume
23.66K
P/E ratio
73.69
52-wk high
₹290.70
52-wk low
₹91.20
EPS
₹3.29
No. of employees
406
About Bafna Pharmaceuticals Ltd
CEO-
Employees406
Founded1981
Headquarters-
SectorPharmaceutical industry
Websitebafnapharma.com
Last report
Aug 11, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
265.83M / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
354.68M
382.86M
422.39M
265.83M
Cost of goods sold
230.62M
272.68M
297.37M
174.98M
Cost of revenue
230.62M
272.68M
297.37M
174.98M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54.90M
53.45M
54.43M
56.16M
Operating expense
95.97M
95.38M
106.16M
99.84M
Total operating expenses
326.59M
368.06M
403.52M
274.82M
Operating income
28.10M
14.80M
18.87M
-8.99M
Other non operating income
11.80M
12.19M
17.62M
19.11M
EBT including unusual items
31.25M
18.37M
26.20M
751.00K
EBT excluding unusual items
31.25M
18.37M
26.20M
751.00K
Income tax expense
-
-
-1.30M
-
Effective tax rate
-
-
-4.95%
-
Other operating expenses
26.34M
26.23M
35.12M
25.87M
Net income
31.25M
18.37M
27.49M
751.00K
Net profit margin
8.81%
4.80%
6.51%
0.28%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-8.64M
-8.62M
-10.29M
-9.37M
Net interest expenses
-8.64M
-8.62M
-10.29M
-9.37M
Depreciation and amortization charges
14.73M
15.70M
16.60M
17.81M
EBITDA
42.31M
27.02M
34.05M
6.19M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps